Drugs / Herceptin US
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02594761 Comparator | Aug 2013 → Feb 2014 | — | Mylan Pharmaceuticals Inc | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Herceptin US | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02594761 ↗ |
| Route | Intravenous | “Herceptin US: 8 mg/kg i.v. infusion over 90 minutes” NCT02594761 ↗ |